Johnson & Johnson (NYSE: JNJ) today announced it has completed its acquisition of Intra-Cellular Therapies, Inc. Intra-Cellular Therapies is now part of Johnson & Johnson and will operate as a ...
Bankruptcy judge rejects the healthcare-products company’s third attempt to resolve mass talc lawsuits through chapter 11.
Johnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “neutral” rating reaffirmed by analysts at Guggenheim in a ...
1 Janssen Inc., a Johnson & Johnson company, is the market authorization holder for LAZCLUZE ® and RYB Johnson & Johnson (NYSE: JNJ) today announced positive topline results from ANTHEM-UC ...
A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results